November 1 CBPP Spotlight

During a Targeted Oncology Case Based Peer Perspectives event, Marc Matrana, MD, MS, discussed the case of a 62-year-old male patients with renal cell carcinoma.

The results from the phase 3 CASPIAN trial were reviewed and compared with the phase 3 IMpower133 by Jyoti D. Patel, MD, during a Targeted Oncology Case Based Peer Perspectives event.

Comparing the efficacy of selective HER2 kinase inhibitors in HER2-positive metastatic breast cancer, it was shown that tucatinib may have been approved in the second-line setting due to it's unique impact on the central nervous system. Another HER2 inhibitor, trastuzumab deruxtecan has demonstrated promise in a phase 2 study and is now being confirmed in a phase 3 study.

During a Targeted Oncology Case Based Peer Perspectives event, Antoinette Wozniak, MD, discussed the case of a 59-year-old man with non-small cell lung cancer.

During the Targeted Oncology Case Based Peer Perspectives event, Javier L. Munoz, MD, Hematologist/Oncologist Director, Lymphoma Program Mayo Clinic, discussed the case of 60-year-old patient with peripheral T-cell lymphoma.

During a Targeted Oncology Case Based Peer Perspective event, Erlene Seymour, MD, reviewed the front-line treatment options for chronic lymphocytic leukemia.

During a Targeted Oncology Case Based Peer Perspectives event, John Heymach, MD, PhD, professor and Chair, David Bruton Jr Chair in Cancer Research. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, discussed the guidelines and therapeutic option for stage III non–small cell lung cancer, based on a case of a 66-year-old patient.

During a Targeted Oncology Case Based Peer Perspective event, Usama Gergis, MD, MBA, discussed the case of a 48-year-old male patient with acute graft-versus-host-disease.

During a Targeted Oncology Case Based Peer Perspective event, Marc Hoffman, MD, reviewed the case of a 53-year-old woman with relapsed chronic lymphocytic leukemia.

During a Targeted Oncology Case Based Peer Perspective event, Ramez N. Eskander, MD, reviewed the case of a 69-year-old woman with newly diagnosed ovarian cancer.

During a Targeted Oncology Case Based Peer Perspective event, Corey J. Langer, MD, discussed options for a 63-year-old patient with stage III non–small cell lung cancer.